Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-PLAQUE
NCT06767345Phase 4Active, not recruiting
- Sponsor
- Korea University Anam Hospital
- Start
- May 2025
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe, rosuvastatin in coronary artery disease (CAD), atherosclerosis, sponsored by Korea University Anam Hospital. Started May 2025; status: active, not recruiting.
02
Drugs
ezetimiberosuvastatin
03
Conditions
coronary artery disease (CAD)atherosclerosis
Beyond the preview
Go deeper on NCT06767345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06767345.